ClinicalTrials.Veeva

Menu

30 Day Rehospitalization Risk in Hemodialysis Patients

Northwell Health logo

Northwell Health

Status

Terminated

Conditions

Re-hospitalization Hemodialysis

Treatments

Other: Checklist driven clinical encounter after hospital discharge

Study type

Interventional

Funder types

Other

Identifiers

NCT02553564
Nephrology - 06032015

Details and patient eligibility

About

After a hospitalization, dialysis patients have a high risk of being admitted to the hospital again within 30 days. The purpose of this research study is to test a new way of reducing the chance of patients being hospitalized again. In this study investigator will evaluate a checklist driven evaluation upon return to the dialysis facility as a method to reduce the rate of rehospitalizations in hemodialysis patients.

Full description

There are an excessive number of 30 day readmissions after hospital discharges of dialysis patients in the U.S. (35.2%). Investigators recent research has found that approximately 2/3 of these readmissions are potentially avoidable. Investigators believe that among the causes for the excessive number of readmissions, the most important may be that patients usually do not receive a clinical assessment upon return to dialysis after a hospitalization. An all too common practice in the U.S. is for the nephrologist to not see the patient but to give verbal orders to the dialysis nurse to resume previous orders. This increases readmission risk in that there are a number of key clinical processes that if completed on return to dialysis might greatly reduce rehospitalization risk. Nephrologists are often not available to see patients in the peri-discharge period, but there is a trend towards an increasing number of U.S. dialysis facilities now having nurse practitioners (NP) working in the units. Investigators believe that NPs using a checklist can conduct a post-discharge clinical encounter that would allow for key care processes to be carried out and to direct telephone communication with the treating nephrologist. Our objective is to reduce the risk of dialysis patient readmissions within 30 days through the use of this intervention. Our research question is whether this intervention would be effective for reducing 30 day readmission risk. Our hypothesis is that the intervention will prove to be more effective then usual care for reducing 30 day readmission risk.

Enrollment

3 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18 years of age or older
  • Must have been an existing patients of the outpatient dialysis units for at least 1 month prior to the index hospitalization
  • Index hospitalization must be from an acute care hospital

Exclusion criteria

  • Hospital discharges against medical advice
  • Assessment cannot be initiated within 96 hours of hospital discharge
  • Primary hospital diagnosis related to cancer, renal transplant, mental health or rehabilitation
  • Hospital admission was the 5th or more in the previous 12 months
  • Failure to provide informed consent

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

3 participants in 2 patient groups

Intervention group
Experimental group
Description:
Checklist driven clinical encounter after hospital discharge - Participant will receive standard medical care with the addition of a checklist driven clinical encounter upon return to the dialysis unit after hospital discharge. \* participants in both group will be receiving standard post discharge care which includes nursing assessment, social work intervention as needed and new dialysis orders.
Treatment:
Other: Checklist driven clinical encounter after hospital discharge
Usual care group
No Intervention group
Description:
Participant will receive standard medical care upon return to the dialysis unit after hospital discharge. \* participants in both group will be receiving standard post discharge care which includes nursing assessment, social work intervention as needed and new dialysis orders.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems